The anticipated cost-of-living adjustment, commonly referred to as COLA, for Social Security beneficiaries in 2026 has recently increased to 2.4% based on the latest inflation data. This figure represents a slight rise from estimates provided last month but remains below the 2.5% COLA that retirees enjoyed in 2025. This adjustment signifies a critical aspect of financial planning for many seniors.
There is a possibility that this could be the smallest benefit increase seen in the past five years, which raises concerns among beneficiaries.
While inflation seems to be easing — at least for the moment — experts caution that the 2026 COLA might not adequately address the actual expenses that many older Americans are encountering. These expenses particularly relate to essential needs such as housing, groceries, and medical care, which continue to rise sharply.
The annual COLA is determined using the Consumer Price Index for Urban Wage Earners and Clerical Workers, known as CPI-W. As of April, the CPI-W reflected a modest increase of only 2.1% compared to the previous year, indicating a slowdown in overall inflation.
While this may initially seem like a positive development, the reality is more complex. Many of the primary financial burdens faced by older adults, including costs for food, housing, and insurance, remain stubbornly high. A recent report from independent Social Security and Medicare policy analyst Mary Johnson highlighted that “Consumer prices remain stubbornly higher for certain items, notably groceries — especially animal-based protein sources like meats and eggs.” [and]
Both Johnson and the Senior Citizens League, a nonprofit advocacy organization, are forecasting a 2026 COLA adjustment of 2.4%.
Executive Order on Drug Prices: Potential Changes Ahead
The CPI-W does not fully capture the spending patterns of retirees, particularly regarding the significant healthcare costs that older Americans incur. As a result, COLAs frequently fall short of adequately supporting seniors’ financial requirements. However, an exception to this trend has been observed in the realm of prescription medications.
Data from the Bureau of Labor Statistics reveals that drug prices have only risen by 2.3% over the past year, marking a significant slowdown compared to previous years. This moderation in costs is largely attributed to provisions within the Inflation Reduction Act, a law enacted in 2022 that mandates drug manufacturers to provide rebates to Medicare if their prices rise faster than inflation.
Mary Johnson emphasized that “That provision, which was widely supported by Medicare beneficiaries, could be restraining runaway drug prices.”
Additionally, in 2025, a new cost-saving initiative was introduced: a $2,000 cap on out-of-pocket expenses for Medicare-covered prescription medications. This change offers vital relief to older adults managing chronic health conditions.
Complicating the landscape is a recent executive order from former President Donald Trump promoting “most-favored nation” pricing for prescription drugs, which encourages linking U.S. drug prices to those in other countries, where government-negotiated rates tend to be much lower.
However, Johnson cautioned that this order might not yield significant practical benefits in the near term. “An executive order… is not the same thing as a law change giving Medicare the authority to use these prices in negotiations with drug companies,” she pointed out.
According to Johnson, the policy appears to support direct-to-consumer imports of lower-priced medications from abroad, which may not directly influence Medicare-covered drug pricing.
“If that doesn’t muddy the waters enough, one has to wonder what effect tariffs would have on the final drug prices,” she added, highlighting how tariff policies could potentially increase costs.
The official COLA announcement is scheduled for October when the Social Security Administration finalizes inflation data for the months of July, August, and September. Until that time, analysts will continue to revise their projections as new inflation reports are released. Johnson’s analysis indicates that her forecast “may still underestimate the final 2026 COLA,” particularly given the impending trade and healthcare policy changes.
For the moment, Social Security beneficiaries should brace for a modest increase in their benefits starting in January while remaining vigilant about economic trends and the actions of policymakers in Washington, D.C. that might still influence the ultimate outcome.
Essential Insights on Social Security and Drug Prices
Discover why some individuals will receive two Social Security checks in May.
Learn about the White House’s plans to eliminate Social Security payments made by paper checks.
Explore the nine states that still impose taxes on Social Security benefits.
